- Supported exchanges /
- F /
- 4QG.F
PCI BIOTECH ASA NK 3 (4QG F) stock market data APIs
PCI Biotech Holding ASA, a biopharmaceutical company, focuses on the development and commercialization of novel therapies for the treatment of cancer through its photochemical internalization (PCI) technology platform. The company's technology platform consists of a proprietary small molecule photosensitiser (fimaporfin) and a light source; and develops photochemical internalisation (PCI), inducing light-triggered intracellular release for various therapeutic modalities, as well as photochemical lysis (PCL) comprising light-triggered cell lysis, which enhances yield and purity in viral vector manufacturing. It also explores for intratumoural immunotherapy therapeutics that identifies novel treatment combinations to overcome resistance to immune-checkpoint inhibitors and safety-issues associated with treatments; and develops nucleic acid therapeutics to improve the treatment of dermatological diseases. In addition, the company develops fimaVACC for immunotherapy indications, which is in pre-clinical study; fimaNAc, a nucleic acid therapeutics delivery technology, which is in pre-clinical study for bioprocessing and dermatology indications; and technology for viral vector manufacturing and pre-clinical research for intratumoural immunotherapy. PCI Biotech Holding ASA was incorporated in 2007 and is headquartered in Oslo, Norway.
PCI BIOTECH ASA NK 3 Financial Data Overview
| 0.1354 | |
| 0.1354 | |
| - | |
| 0.1354 | |
| 0.1354 | |
| 0.1064-0.23 | |
| 5 110 K | |
| 37 326 K | |
| 5 999 K | |
| 1.73 |
No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.
PCI BIOTECH ASA NK 3 Fundamental Data is available in our Financial Data APIs
- Net Revenue 5 999 K
- EBITDA -17 812 000
- Earnings Per Share -0.04
- Income Statements
- Balance Sheets
- Cash flows
of Fundamental API Data
Get PCI BIOTECH ASA NK 3 Earnings via APIs
- Latest Release NaN
- EPS/Forecast NaN
Get PCI BIOTECH ASA NK 3 End-of-day Data via APIs
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Our 24/7 support would be happy to assist you via chat or email:
support@eodhistoricaldata.comVisit also:
